Microbot Medical's (MBOT) stock gains as its Liberty surgical robotic system achieves 100% success in trials, hitting the ...

Microbot Medical Inc.’s MBOT share price has surged by 15.92%, which has investors questioning if this is right time to sell.

With its remote endovascular procedure system currently under review at the FDA, Microbot Medical has put forward positive ...

Microbot Medical today announced pivotal trial data supporting the use of its Liberty endovascular surgical robot.

Microbot Medical (MBOT) presented for the first time the data from its ACCESS-PVI pivotal trial at the Society of Interventional Radiology ...

Microbot reported positive data on its single-use endovascular robot. Elsewhere, GE Healthcare named a new business leader, ...

Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, presented for the first time the data from its ACCESS-PVI pivotal trial at the Society of ...

Shares of Microbot Medical (NASDAQ:MBOT) rose in the premarket on Wednesday after the MedTech firm announced that a pivotal trial for its Liberty endovascular surgical robotic system reached the ...

HINGHAM, Mass. - Microbot Medical Inc. (NASDAQ:MBOT), a pre-commercial stage medical technology company with a market capitalization of $48 million, announced the results of its ACCESS-PVI pivotal ...